| Dr James John Herget, DDS | |
|
1766 Horicon St, Mayville, WI 53050-1256 | |
| (920) 387-5810 | |
| (920) 387-9201 |
| Full Name | Dr James John Herget |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 1766 Horicon St, Mayville, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851396931 | NPI | - | NPPES |
| 33771500 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 3919-015 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James John Herget, DDS 1766 Horicon St, Mayville, WI 53050-1256 Ph: (920) 387-5810 | Dr James John Herget, DDS 1766 Horicon St, Mayville, WI 53050-1256 Ph: (920) 387-5810 |
News Archive
American researchers from the Institute for Biomedical Sciences at Georgia State University have found that certain foods such as cheese, cookies, French fries, energy drinks, soda, and other types of junk foods are found more frequently in the diets of adults suffering from inflammatory bowel disease (IBD).
A device designed by a team of faculty and student researchers at Sheridan's Centre for Mobile Innovation (CMI) has the potential to impact the diagnosis of community-acquired pneumonia - a significant cause of death for children worldwide, according to the World Health Organization.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
Infants exposed to a diverse range of bacterial species in house dust during the first year of life appear to be less likely to develop asthma in early childhood, according to a new study published online on June 6, 2014, in the Journal of Allergy and Clinical Immunology.
› Verified 5 days ago
Dr. Mark Christian Brieman, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 105 Bridge St, Mayville, WI 53050 Phone: 920-387-2640 Fax: 920-387-0240 | |
Nicholas Anthony Novotny, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1766 Horicon St, Mayville, WI 53050 Phone: 920-387-2640 | |
Dr. Daniel Stevens, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 105 Bridge St, Mayville, WI 53050 Phone: 920-387-2640 |